PATENT CLAIM ANALYSIS

Application Number: 16045358
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["544", "281000"]

Abstract:
This application relates to compounds of Formula (I): or pharmaceutically acceptable salts or stereoisomers thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.

Claim (Index 95):
The method of  claim 78 , wherein disease or disorder is lung cancer, melanoma, breast cancer, acute myeloid leukemia, acute monocytic leukemia, chronic myelogenous leukemia (CML), multiple myeloma, acute myeloblastic leukemia, chronic myeloid leukemia, or smouldering myeloma.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.27778
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15343375', '15631417', '13085643', '13329532', '14872881']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8336862744931517
- 35 USC 102 Novelty (BERT): 0.571075308612837
- Combined Prediction Score: 0.8074251779051203
- Mean Citation Score: 421.74511
- Max Citation Score: 495.84445
- Similarity Product: 233.9099896134585

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test